Literature DB >> 27995361

Bladder and bowel dysfunctions in 1748 children referred to pelvic physiotherapy: clinical characteristics and locomotor problems in primary, secondary, and tertiary healthcare settings.

Marieke L van Engelenburg-van Lonkhuyzen1, Esther M J Bols2, Marc A Benninga3, Wim A Verwijs4, Rob A de Bie2.   

Abstract

The aims of this study are to evaluate in a pragmatic cross-sectional study, the clinical characteristics of childhood bladder and/or bowel dysfunctions (CBBD) and locomotor problems in the primary through tertiary health care setting. It was hypothesized that problems would increase, going from primary to tertiary healthcare. Data were retrieved from patient-records of children (1-16 years) presenting with CBBD and visiting pelvic physiotherapists. Prevalence's of dysfunctions were compared between healthcare settings and gender using ANOVA and chi-square test. Agreement between physicians' diagnoses and parent-reported symptoms was evaluated (Cohen's Kappa). One thousand seventy hundred forty-eight children (mean age 7.7 years [SD 2.9], 48.9% boys) were included. Daytime urinary incontinence (P = 0.039) and enuresis (P < 0.001) were more diagnosed in primary healthcare, whereas constipation (P < 0.001) and abdominal pain (P = 0.009) increased from primary to tertiary healthcare. All parent-reported symptoms occurred more frequently than indicated by the physicians. Poor agreement between physicians' diagnoses and parent-reported symptoms was found (k = 0.16). Locomotor problems prevailed in all healthcare settings, motor skills (P = 0.041) and core stability (P = 0.015) significantly more in tertiary healthcare.
CONCLUSIONS: Constipation and abdominal pain (physicians' diagnoses) and the parent-reported symptoms hard stools and bloating increased from primary to tertiary healthcare. Discrepancies exist between the prevalence's of physicians' diagnoses and parent-reported symptoms. Locomotor problems predominate in all healthcare settings. What is Known: • Childhood bladder and/or bowel dysfunctions (CCBD) are common. • Particularly tertiary healthcare characteristics of CBBD are available What is New: • Characteristics of CBBD referred to pelvic physiotherapy are comparable in primary, secondary, and tertiary healthcare settings. • Concomitant CBBD appeared to be more prevalent than earlier reported. • Discrepancies exist between referring physicians' diagnoses and parent-reported symptoms.

Entities:  

Keywords:  Constipation; Enuresis; Incontinence; Motor control; Pelvic floor muscles; Questionnaire

Mesh:

Year:  2016        PMID: 27995361      PMCID: PMC5243895          DOI: 10.1007/s00431-016-2824-5

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


Introduction

Childhood bladder and/or bowel dysfunctions (CBBD) are common worldwide [1-5]. Bladder dysfunctions are daytime urinary incontinence (DUI), enuresis, and overactive bladder syndrome. The prevalence of DUI and enuresis decreases with age. The peak prevalence of DUI in girls is 8.4% at the age of 7 years, gradually decreasing to 4% in adolescence, whereas the corresponding prevalence rates for boys are 1.4 and 0.9%, respectively [6-8]. Enuresis is a complex condition, involving multiple pathogenic factors [9]. Prevalence’s vary, depending on the definition, approximately 10–20% of all 5-year-olds regularly wet their beds and the prevalence decreases by about 15% each year [10]. Generally accepted is that enuresis is more common in boys than in girls but only until the teenage years [11, 12]. The overactive bladder syndrome is found in 60 to 70% of children with urinary incontinence [13]. Bowel dysfunctions constitute of constipation and fecal incontinence (FI). Estimates of constipation in the general pediatric population range from 0.3 to 8%, with boys and girls equally affected. FI is one of the most common presentations of constipation and is found in up to 84% of constipated children at presentation [4]. FI is estimated to affect 0.8 to 7.8% children in Western societies with reported boys to girls’ ratio’s ranging from 3:1 to 6:1 [14-17]. CBBD have a major impact on a child’s psychosocial functioning. Comorbid behavioral disorders in about 20 to 40% of children with CBBD affect the everyday life of the children and their family [13, 14, 18–21]. The first treatment option of CBBD is a relaxed toileting posture and effective straining to defecate, which requires sufficient locomotor skills [4, 22]. The pelvic floor muscles (PFM) assist in maintaining urinary and fecal continence and, opposite to it, in adequate urination and defecation. Moreover, the PFM cooperate in close synergy with the diaphragm and the abdominal muscles. Therefore, the PFM are also involved in breathing and stabilizing connecting joints and the lower back [23-27]. This means that an unstable or tensed posturing on the toilet, in which the PFM are unable to relax properly, can cause an inadequate urinary flow or bowel movement. From this point of view, CBBD might be related to impaired locomotor skills, although evidence for this hypothesis is lacking. In the Netherlands, standard medical care for CBBD is initially delivered by the general practitioner, but patients are also allowed to visit a private pelvic physiotherapist (PPT) without referral from a general practitioner or medical specialist. In case of unsatisfactory results, the child can be referred to a pediatrician at a general hospital (secondary healthcare). University-hospital care (tertiary healthcare) is required when secondary healthcare fails. Next, to support SMC, patients can be referred from medical doctors (primary, secondary, and tertiary healthcare) to primary healthcare PPT. Consequently, children visiting a PPT form a heterogeneous group of all ages and CBBD problems. Limited data is available on the clinical characteristics and complexity of (concomitant) CBBD (physician and parent-reported) in primary and secondary healthcare, while most CBBD studies conducted in tertiary healthcare settings especially focus on treatment effects [6, 28, 29]. The lack of knowledge of patient characteristics, severity of symptoms and co-morbidities throughout healthcare settings may hamper targeting effective treatments. Furthermore, discrepancies are described between physicians’ diagnoses and parent-reported daily symptoms regarding CBBD [30, 31]. The aims of this pragmatic study are to describe (i) the clinical characteristics of CBBD in, and between, primary, secondary and tertiary healthcare settings, (ii) the level of agreement between referring physicians’ diagnoses and questionnaire-based symptoms, reported by parents and (iii) the relation between CBBD and locomotor problems. It was hypothesized that the prevalence’s of CBBD, comorbidities, and locomotor problems would increase, going from lower-to-higher-level healthcare settings.

Methods

Study design and population

We performed a cross-sectional study in a sample of children, aged 1–16 years, affected with varying forms of bladder and/or bowel dysfunctions, irrespective of the cause or presence of comorbidity and/or behavioral problems. Except age (1–16 years), no exclusions were made. Children from across the Netherlands and visiting primary healthcare PPT-practices were enrolled. They came on their own initiative (self-initiated visit; primary healthcare) or were referred by either the general practitioner (primary), district hospitals (secondary), or university hospitals (tertiary healthcare settings). Participating PPT’s are all expert pelvic physiotherapists who had completed a professional master’s degree in PPT. Physicians’ diagnoses were established based on patient history and additional assessments (e.g., physical examination, flowmetry, etc.), as documented in accepted pediatric Dutch guidelines [32-35]. Prior to the first visit at the PPT, the parents reported symptoms by completing the Childhood Bladder and Bowel Questionnaire (CBBDQ). Data were retrieved from the electronic patient records of the children.

Ethics statement

Informed consent was obtained from all parents and children, aged 12 years and older included in the study.

Web-based electronic patient records

Prior to the first visit at the PPT-practice, parents completed the electronic patient records at home. These included the following components:

Patient history

Age, sex, physicians’ diagnoses (possible diagnoses listed with check boxes and an “other options”-text box), chronicity of the CBBD, medication use, comorbidities, and family history. The parent-reported Strength and Difficulties Questionnaire (SDQ), a brief validated screening questionnaire, for children age 4–17 was used to assess emotional and behavioral problems in child’s daily life [36-38].

Childhood Bladder and Bowel Dysfunction Questionnaire

The CBBDQ is a recently developed evaluative symptom questionnaire based on International Children’s Continence Society recommendations and Rome III criteria for functional gastrointestinal disorders [1, 4, 39, 40], with excellent content and construct validity [40, 41]. The CBBDQ consists of two subscales: (1) the bladder symptoms scale (10 items) and (2) the bowel symptoms scale, including abdominal pain and bloated belly (8 items). The parents were asked to indicate the presence of the symptoms, using a five-point Likert scale [0 (never) to 4 (almost daily or daily)].

Locomotor problems

A seven items questionnaire was developed by experts (PPT’s and pediatric physiotherapists) [42] and used as a measure to report problems in locomotor control and motor learning, motor skills (ability to learn to tie shoelaces, cycle or swim) and starting and performing a task, motor control (core stability), and musculoskeletal problems.

Data analyses

For the descriptive analyses, data are expressed as means and standard deviations for continuous variables or as frequencies and percentages for categorical variables. Comparisons between healthcare settings and gender are made, using analysis of variance for continuous variables and the χ 2 test for categorical variables. The SDQ items are coded as “not true”, “somewhat true”, and “certainly true”. The total difficulties score ranges from 0 to 40. Two categories are distinguished: “close to average to slightly raised” (0–16) and “high to very high” (17–40). To examine the symptom prevalence rates of the CBBDQ, the outcomes were dichotomized, with “never or once in the preceding month” recorded as non-symptomatic and “more than once to (almost) every day in the preceding month” as symptomatic. Possible missing items were imputed as “non-symptomatic”. To compare in individual children for their referring physicians’ diagnoses versus the parent-reported symptoms (as determined by the CBBDQ), the Cohen’s kappa coefficient is calculated with regard to the categories as follows: “≥1 no BBD”, “≥1 bladder dysfunction”, “≥1 bowel dysfunction”, and “≥1 concomitant CBBD”. A kappa coefficient of 0 to 0.4 is interpreted as poor agreement, 0.41 to 0.75 as “fair to good agreement” and above 0.75 as “excellent agreement” [43]. A P-value <0.05 was considered to indicate statistical significance. Statistical analyses were performed with SPSS software, version 23 (IBM Corporation, Somers, NY, USA).

Results

Baseline patient characteristics

Participants

Table 1 presents the baseline characteristics of the 1748 children (855 boys; mean age 7.6 years [SD 2.8], 893 girls; mean age 7.7 years [SD 2.9]) included from May 2010 to May 2015. No significant differences were found in age and gender between the healthcare settings. One thousand five hundred children (87%) were referred to PPT by a general practitioner or a medical specialist, like a pediatrician, urologist, nephrologist, or pediatric gastroenterologist, while 13% were self-initiated visits.
Table 1

Baseline patient characteristics between healthcare settings

Total1-HC2-HC3-HC P valuea
n = 1748 n = 731 n = 906 n = 111
(41.7)(51.9)(6.4)
Participants
Age (years)Mean ± SD7.7 ± 2.97.5 ± 2.97.8 ± 2.87.9 ± 3.20.27
Boys855 (48.9)385 (52.6)414 (45.4)56 (51.3)
Age (years)Mean ± SD7.6 ± 2.87.4 ± 2.87.9 ± 2.87.6 ± 2.90.25
Girls893 (51.1)345 (47.3)493 (53.6)55 (48.7)
Age (years)Mean ± SD7.7 ± 2.97.6 ± 3.07.8 ± 2.88.2 ± 3.50.27
Parentsb Single parent113 (6.7)46 (6.7)59 (6.7)8 (7.1).
Two parents1429 (85.1)589 (85.7)749 (84.8)91 (83.5)
Newly formed family137 (8.2)52 (7.6)75 (8.5)10 (7.3)
Siblings1481 (88.2)603 (87.8)779 (88.2)99 (90.8)0.39
Problems at homec 236 (13.5)96 (13.2)128 (14.1)12 (5.1)0.27
Childhood bladder and bowel dysfunctions (physicians’ diagnoses)
Daytime urinary incontinence602 (34.3)274 (37.6)296 (32.6)32 (28.3)0.039*
Constipation549 (31.4)164 (22.5)341 (37.6)44 (38.9)<0.001*
Enuresis493 (28.2)243 (33.3)229 (25.2)21 (18.9)<0.001*
Fecal incontinence362 (20.7)159 (21.8)178 (19.6)25 (22.1)0.51
Increased voiding frequency267 (15.3)114 (15.7)141 (15.5)12 (10.6)0.37
Urinary tract infections210 (12.0)48 (6.6)142 (15.7)20 (17.7)<0.001*
Abdominal pain457 (26.1)163 (22.4)259 (28.6)35 (31.0)0.009*
Withholding behavior
At least one bladder dysfunction1122 (64.2)486 (66.8)572 (63.1)64 (55.6)0.069
At least one bowel dysfunction793 (45.4)286 (36.1)445 (49.1)62 (54.9)<0.001*
CBBD321 (18.4)116 (15.9)183 (20.2)22 (19.5)0.083
Other health problemsd 126 (7.4)26 (3.7)80 (8.8)20 (18.7)<0.001*
Medicatione Bladder183 (10.5)77 (10.6)89 (9.8)17 (15.0)0.23
Bowel787 (45.4)287 (39.7)440 (48.9)60 (53.1)<0.001*
Parent-completed SDQ, age 4–16 years
Analyzed = 1559Range
close to average to slightly raised0–161386 (88.9)547 (87.1)749 (90.0)90 (90.9)
high to very high17–40173 (11.1)81 (12.9)83(10.0)9 (9.1)
Total difficulties score0–409.2 ± 5.79.5 ± 5.89.0 ± 5.78.5 ± 5.50.15

HC healthcare setting (1 primary; 2 secondary; 3 tertiary); SDQ Strength and Difficulties Questionnaire; CBBD Both, bladder and bowel dysfunction. Data are presented as number (n) and percentage (%) (or otherwise circumscribed, mean and ± standard deviation (SD))

aANOVA or Pearson’s chi-square

bmissing 4.9% (P = 0.93)

cDivorce of parents, death of a parent or grandparent, sibling or pet, moving house, stress at home

dPulmopathy/asthma (2.2%); feeling sick/failure to thrive (1.7%); allergy/eczema (0.8%); neurological disorders (0.7%); endocrine or metabolic disorders (0.5%); musculoskeletal disorders (0.5%); gynecologic disorders (0.4%); complex disorders (0.3%); otopathy (0.2%); cardiopathy (0.2%); psychiatric disorders (0.2%); cystic fibrosis (0.1%); other gastrointestinal tract disorders (0.1%); not otherwise specified (0.4%)

eBladder: overactive bladder, enuresis and current urinary tract infection; bowel: laxatives

*Significant at the P < 0.05 level

Baseline patient characteristics between healthcare settings HC healthcare setting (1 primary; 2 secondary; 3 tertiary); SDQ Strength and Difficulties Questionnaire; CBBD Both, bladder and bowel dysfunction. Data are presented as number (n) and percentage (%) (or otherwise circumscribed, mean and ± standard deviation (SD)) aANOVA or Pearson’s chi-square bmissing 4.9% (P = 0.93) cDivorce of parents, death of a parent or grandparent, sibling or pet, moving house, stress at home dPulmopathy/asthma (2.2%); feeling sick/failure to thrive (1.7%); allergy/eczema (0.8%); neurological disorders (0.7%); endocrine or metabolic disorders (0.5%); musculoskeletal disorders (0.5%); gynecologic disorders (0.4%); complex disorders (0.3%); otopathy (0.2%); cardiopathy (0.2%); psychiatric disorders (0.2%); cystic fibrosis (0.1%); other gastrointestinal tract disorders (0.1%); not otherwise specified (0.4%) eBladder: overactive bladder, enuresis and current urinary tract infection; bowel: laxatives *Significant at the P < 0.05 level

Referring physicians’ diagnoses

The most common referred diagnoses were daytime urinary incontinence (DUI; 34.3%), constipation (31.4%), enuresis (28.2%), and fecal incontinence (FI; 20.7%) while 26.1% of the children were referred with abdominal pain and 12.0% with urinary tract infections. No differences between health care settings were found with respect to chronicity of any complaints. Laxative use increased going from primary to tertiary care, and these agents were prescribed to 45.4% of the children, whereas medication for bladder dysfunctions was prescribed to 10.5% of the children. A total of 1122 (64.2%) of the children were referred with at least one bladder dysfunction, 793 (45.4%) with at least one bowel dysfunction, and 321 children (18.4%) with both, bladder, and bowel dysfunctions. Significantly, more DUI (P = 0.039) and enuresis (P < 0.001) were diagnosed in primary healthcare. Urinary tract infection, especially among girls, increased going from primary to tertiary healthcare settings (P = <0.001). Boys had less frequent bladder dysfunctions (P = 0.022) in tertiary care and less bowel dysfunctions in primary healthcare (P < 0.001). Whereas constipation (P < 0.001) and abdominal pain (P = 0.009) were more diagnosed in secondary and tertiary healthcare and more prevalent among girls (P < 0.001) (Table 2). FI was more common among boys in all settings (P < 0.001). The number of children referred with “at least one bowel dysfunction” increased, going from primary to tertiary healthcare settings (P < 0.001). Other health problems, such as lung diseases, also increased significantly from 3.7 to 18.7% (P < 0.001).
Table 2

Gender-specific childhood bladder and bowel dysfunctions between healthcare setting (physicians’ diagnosis)

GenderTotal1-HC2-HC3-HC P valuea
n = 1748 n = 731 n = 906 n = 111
(41.8)(51.9)(6.4)
Childhood Bladder and Bowel Dysfunctions (physicians’ diagnoses)
Daytime urinary incontinenceB versus Gb 0.65
 boys229 (35.0)138 (36.0)147 (35.5)14 (24.1)0.20
 girls303 (33.9)136 (39.4)149 (30.2)18 (32.7)0.022*
ConstipationB versus Gb <0.001*
 boys225 (26.3)56 (14.5)149 (36.0)20 (35.7)<0.001*
 girls324 (36.6)108 (31.3)192 (38.9)24 (43.6)0.039*
EnuresisB versus Gb <0.001*
 boys320 (37.4)160 (41.6)147 (35.5)13 (23.2)0.016*
 girls173 (19.4)83 (24.1)82 (16.6)8 (14.5)0.018*
Fecal incontinenceB versus Gb <0.001*
 boys232 (27.1)104 (27.0)113 (27.3)15 (26.8)0.048*
 girls130 (14.6)56 (16.2)65 (13.2)9 (16.4)0.22
Increased voiding frequencyB versus Gb 0.51
 boys136 (15.9)56 (14.6)74 (17.9)6 (10.3)0.23
 girls131 (14.7)58 (16.8)67 (13.6)6 (10.9)0.32
Urinary tract infectionsB versus Gb <0.001*
 boys18 (2.1)6 (1.6)11 (2.7)1 (1.7)0.63
 girls192 (21.5)42(12.2)131(26.6)19 (34.5)<0.001*
Abdominal painB versus Gb <0.001*
 boys167 (19.5)61 (15.9)93 (22.5)13 (22.4)0.056
 girls290 (32.5)102 (29.6)166 (33.7)22 (40.0)0.22
Withholding behaviorB versus Gb 0.71
 boys234 (27.4)121 (31.4)102 (24.6)11 (19.6)0.040*
 girls252 (28.2)124 (35.9)110 (22.3)18 (32.7)<0.001*
At least one bladder dysfunctionB versus Gb 0.32
 boys554 (64.8)265 (68.8)260 (62.8)29 (51.8)0.022*
 girls568 (63.6)222 (64.3)312 (63.3)34 (61.8)0.91
At least one bowel dysfunctionB versus Gb 1.0
 boys388 (45.4)142 (36.9)214 (51.7)32 (56.9)<0.001*
 girls405 (45.4)145 (42.0)231 (46.9)29 (52.7)0.20
Both, bladder and bowel dysfunctionB versus Gb 0.76
 boys160 (18.7)63 (16.4)88 (21.3)9 (16.1)0.18
 girls161 (18.0)54 (15.7)95 (19.3)12 (21.8)0.30

HC healthcare setting (1 primary; 2 secondary; 3 tertiary). Data are presented as number (n) and percentage (%)

aPearson’s chi-square or Fisher’s exact test

bB versus G; boys versus girls between healthcare settings

*Significant at the P < 0.05 level

Gender-specific childhood bladder and bowel dysfunctions between healthcare setting (physicians’ diagnosis) HC healthcare setting (1 primary; 2 secondary; 3 tertiary). Data are presented as number (n) and percentage (%) aPearson’s chi-square or Fisher’s exact test bB versus G; boys versus girls between healthcare settings *Significant at the P < 0.05 level

Strength and Difficulties Questionnaire

As depicted in Table 1, no significant differences in SDQ were found between healthcare settings. On a range of 0–40, the mean total SDQ difficulties scores were 9.5 (SD 5.8), 9.0 (SD 5.7), and 8.5 (SD 5.5) for primary, secondary, and tertiary healthcare, respectively, and 11.1% of the children had a total SDQ-difficulties score over 16, indicating the children had emotional or behavioral problems.

Parent-reported symptoms

Parent-reported symptoms are described in Table 3 (proportions between healthcare settings) and Table 4 (gender-specific). Based on the parent-reported symptoms, bladder problems like DUI occurred more often in primary healthcare than in secondary and tertiary healthcare (P = 0.023). High prevalence of ignoring the urge to urinate (53.0%) and urgency (56.6%) were found in all healthcare settings, whereby “ignoring” decreased significantly (P = 0.023) from primary to tertiary healthcare setting. Boys have more DUI than girls (P = 0.006), especially in secondary and tertiary healthcare settings and post-micturition dribble (P = 0.003), decreasing from primary to tertiary healthcare settings. Boys were more likely to suffer from enuresis than girls (P < 0.001). In contrast, girls wake up at night to urinate more often (P = 0.045).
Table 3

Childhood bladder and bowel dysfunctions (parent-reported) between HC-settings

Total1-HC2-HC3-HC P valuea
n = 1748 n = 730 n = 907 n = 111
Items of the Childhood Bladder and Bowel Dysfunction Questionnaireb
1 Passes urine more than 8 times during the day676 (38.7)289 (39.6)355 (39.1)32 (28.8)0.087
2 Wets underwear and /or outer clothing during the day859 (49.1)383 (52.5)430 (47.4)46 (41.4)0.031*
3 Loses some drops of urine immediately after urinating has finished684 (39.1)302 (41.4)347 (38.3)35 (31.5)0.40
4 Loses urine within the hour after urinating has finished518 (29.6)225 (30.8)267 (29.4)26 (23.4)0.28
5 Seems to ignore the urge to urinate927 (53.0)407 (55.8)473 (52.1)47 (42.3)0.023*
6 Uses tricks to stay dry, like wriggling or forcefully crossing the legs597 (34.2)261 (35.8)303 (33.4)33 (29.7)0.36
7 Experiences a sudden uncontrollable urge to urinate989 (56.6)422 (57.8)510 (56.2)57 (51.4)0.42
8 Postpones first urination in the morning505 (28.9)203 (27.8)268 (29.5)34 (30.6)0.68
9 Wets the bed or diaper during sleeping periods742 (42.4)339 (46.4)362 (39.9)41 (36.9)0.014*
10 Wakes up at night to urinate353 (20.2)128 (17.5)203 (22.4)22 (19.8)0.052
11 Has two or fewer bowel movements per week373 (21.4)169 (23.2)176 (19.4)28 (25.2)0.11
12 Stains or soils the underwear with stools778 (44.5)335 (45.9)385 (42.4)58 (52.3)0.09*
13 Has hard stools or painful bowel movements414 (23.7)150 (20.5)232 (25.6)32 (28.8)0.025*
14 Has large amounts of stool (that may obstruct the toilet)345 (19.7)147 (20.1)168 (18.5)30 (27.0)0.10
15 Postpones bowel movements616 (35.2)292 (40.0)286 (31.5)38 (34.2)0.002*
16 Experiences a sudden uncontrollable urge to defecate763 (43.7)326 (44.7)389 (42.9)48 (43.6)0.77
17 Has abdominal pain699 (40.1)270 (37.1)383 (42.3)46 (41.4)0.10
18 Has a bloated belly415 (23.7)157 (21.5)214 (23.6)44 (39.6)<0.001*
At least one bladder symptom1566 (89.6)668 (91.5)805 (88.8)93 (83.8)0.023*
At least one bowel symptom1404 (80.3)589 (80.7)722 (79.6)93 (83.8)0.55
Combined bladder and bowel symptom1266 (72.4)539 (73.8)647 (71.3)80 (72.1)0.53

HC healthcare setting (1 primary, 2 secondary, 3 tertiary). Data are presented as number (n) and percentage (%)

aPearson’s chi-square

bLikert scale for symptoms on all items are (never–(nearly) every day) dichotomized: “Never or once in the past month” classified as “non-symptomatic” (no); “more than once in the past month to (nearly) every day in the past month” classified as “symptomatic” (yes). Missing items were imputed as “non-symptomatic”

*Significant at the P < 0 05 level

Table 4

Childhood Bladder and Bowel Dysfunction Questionnaire (parent-reported symptoms) gender-specific

GenderTotal1-HC2-HC3-HCP valuea
n = 1748 n = 730 n = 907 n = 111
Items of the Childhood Bladder and Bowel Dysfunction Questionnaireb
1 Passes urine more than 8 times during the dayB versus Gc 0.057
 boys350 (40.9)163 (42.3)170 (41.1)17 (30.4)0.23
 girls326 (36.5)126 (36.5)185 (37.5)15 (27.3)0.33
2 Wets underwear and /or outer clothing during the dayB versus Gc 0.006*
 boys449 (52.2)213 (47.4)212 (48.8)32 (57.1)0.17
 girls410 (45.9)170 (49.3)218 (44.2)22 (40.0)0.23
3 Loses some drops of urine immediately after urinating finishedB versus Gc 0.003*
 boys490 (57.3)173 (44.9)173 (41.8)19 (33.9)0.26
 girls319 (35.7)129 (37.4)174 (35.3)16 (29.1)0.47
4 Loses urine within the hour after urinating has finishedB versus Gc 0.08
 boys270 (31.6)122 (31.7)131 (31.6)17 (30.4)0.98
 girls248 (27.8)103 (29.9)136 (27.6)9 (16.4)0.12
5 Seems to ignore the urge to urinateB versus Gc 0.006*
 boys482 (56.4)227 (59.0)234 (56.5)21 (37.5)0.010*
 girls445 (49.8)180 (52.2)239 (48.5)26 (47.3)0.53
6 Uses tricks to stay dry, like wriggling or forcefully crossing legsB versus Gc 0.76
 boys295 (34.5)147 (38.2)136 (32.9)12 (21.4)0.030*
 girls302 (33.8)114 (33.0)167 (33.9)21 (38.2)0.76
7 Experiences a sudden uncontrollable urge to urinateB versus Gc 0.04*
 boys505 (59.1)232 (60.3)244 (58.9)27 (48.2)0.48
 girls484 (54.2)190 (55.1)266 (54.0)28 (50.9)0.84
8 Postpones first urination in the morningB versus Gc 0.09
 boys231 (27.0)105 (27.3)112 (27.1)14 (25.0)0.94
 girls274 (30.7)98 (28.4)156 (31.6)20 (36.4)0.39
9 Wets the bed or diaper during sleeping periodsB versus Gc <0.001*
 boys445 (52.0)210 (54.5)208 (46.7)29 (48.2)0.40
 girls297 (33.3)129 (37.4)154 (31.2)14 (25.5)0.079
10 Wakes up at night to urinateB versus Gc 0.01*
 boys151 (17.7)56 (14.5)87 (21.0)8 (14.3)0.045*
 girls202 (22.6)72 (20.9)116 (23.5)14 (25.5)0.58
11 Has two or fewer bowel movements per weekB versus Gc 0.44
 boys176 (20.6)77 (20.0)85 (20.5)14 (25.0)0.014*
 girls197 (22.1)92 (26.7)91 (18.5)14 (25.5)0.69
12 Stains or soils the underwear with stoolsB versus Gc 0.001*
 boys440 (51.5)183 (47.5)202 (48.8)30 (53.6)0.69
 girls363 (40.6)152 (44.1)183 (37.1)28 (50.9)0.037*
13 Has hard stools or painful bowel movementsB versus Gc <0.001*
 boys164 (19.2)58 (15.1)91 (22.0)15 (26.8)0.015*
 girls250 (28.0)92 (26.7)141 (28.6)17 (30.9)0.73
14 Has large amounts of stool (that may obstruct the toilet)B versus Gc 0.57
 boys164 (19.2)65 (16.9)84 (20.3)15 (26.8)0.16
 girls181 (20.3)82 (23.8)84 (17.0)15 (23.7)0.024*
15 Postpones bowel movementsB versus Gc <0.001*
 boys337 (39.4)172 (44.7)150 (36.2)15 (26.8)0.021*
 girls279 (31.2)120 (34.8)136 (27.6)23 (41.8)0.002*
16 Experiences a sudden uncontrollable urge to defecateB versus Gc 0.06
 boys402 (47.0)187 (48.6)192 (46.4)23 (41.1)0.54
 girls361 (40.5)139 (40.3)197 (40.0)25 (46.3)0.66
17 Has abdominal painB versus Gc <0.001*
 boys299 (35.0)128 (33.3)150(36.2)21 (37.5)0.22
 girls400 (44.9)142 (41.3)233 (47.5)25 (45.5)0.64
18 Has a bloated bellyB versus Gc <0.001*
 boys162 (18.9)67 (17.1)77 (18.6)18 (32.1)0.030*
 girls253 (28.3)90 (26.1)137 (27.8)26 (47.3)0.005*
At least one bladder symptomB versus Gc 0.27
 boys773 (90.4)355 (92.2)371 (89.6)47 (83.9)0.11
 girls793 (88.8)313 (90.7)493 (88.0)46 (83.6)0.22
At least one bowel symptomB versus Gc 0.93
 boys686 (80.2)312 (81.0)331 (80.0)43 (76.8)0.74
 girls718 (80.4)227 (80.3)391 (79.3)50 (90.9)0.12
Combined bladder and bowel symptomB versus Gc 0.61
 boys624 (73.0)286 (74.3)300 (72.5)38 (67.9)0.57
 girls642 (71.9)253 (73.3)347 (70.4)42 (76.4)0.48

HC healthcare setting (1 primary, 2 secondary, 3 tertiary). Data are presented as number (n) and percentage (%)

aPearson’s chi-square

bLikert scale for symptoms (never–(nearly) every day) dichotomized: “Never or once in the past month” classified as “non-symptomatic” (no); “more than once in the past month to (nearly) every day in the past month” classified as “symptomatic” (yes). Missing items were imputed as “non-symptomatic”

cB versus G; boys versus girls between healthcare settings

*Significant at the P < 0.05 level

Childhood bladder and bowel dysfunctions (parent-reported) between HC-settings HC healthcare setting (1 primary, 2 secondary, 3 tertiary). Data are presented as number (n) and percentage (%) aPearson’s chi-square bLikert scale for symptoms on all items are (never–(nearly) every day) dichotomized: “Never or once in the past month” classified as “non-symptomatic” (no); “more than once in the past month to (nearly) every day in the past month” classified as “symptomatic” (yes). Missing items were imputed as “non-symptomatic” *Significant at the P < 0 05 level Childhood Bladder and Bowel Dysfunction Questionnaire (parent-reported symptoms) gender-specific HC healthcare setting (1 primary, 2 secondary, 3 tertiary). Data are presented as number (n) and percentage (%) aPearson’s chi-square bLikert scale for symptoms (never–(nearly) every day) dichotomized: “Never or once in the past month” classified as “non-symptomatic” (no); “more than once in the past month to (nearly) every day in the past month” classified as “symptomatic” (yes). Missing items were imputed as “non-symptomatic” cB versus G; boys versus girls between healthcare settings *Significant at the P < 0.05 level

Locomotor problems

Locomotor problems prevailed in all healthcare settings and the prevalence increased with higher-level healthcare settings (Table 5). Parents indicated that 14.5% of all children have had problems in motor learning, 9.2% had problems in core stability, and 10.8% had an increased muscle tension. Children referred from tertiary healthcare settings experienced more problems than those from primary and secondary settings. Significant differences between healthcare settings were found in motor skills (P = 0.041) and core stability problems (P = 0.015). No differences were found with respect to having problems starting or performing a task or musculoskeletal problems.
Table 5

Locomotor problems (parent-reported)

Total1-HC2-HC3-HC P valuea
n = 1674 n = 684 n = 881 n = 109
Motor learning
 Reduced manual dexterityb 175 (10.5)73 (10.7)88 (10.0)14 (12.8)0.64
 Problems of motor skillsc 286 (17.1)99 (14.6)164 (19.0)23 (21.3)0.041*
 Problems starting and performing a taskc 266 (15.9)101 (14.8)145 (16.5)20 (18.5)0.50
Motor control
 Problems in core stabilityc 154 (9.2)51 (7.5)86 (9.8)17 (15.7)0.015*
Musculoskeletal
 Increased muscle tension180 (10.8)76 (12.1)94 (11.3)10 (10.1)0.83
 Reduced muscle tension28 (1.7)13 (1.8)13 (1.4)2 (1.8)0.91

HC healthcare setting (1 primary, 2 secondary, 3 tertiary). Data are presented as number (n) and percentage (%)

aPearson’s chi-square

bCoding of dummy variables: Manual dexterity: normal/increased = 0; reduced = 1

cCoding of dummy variables: Locomotor regarding stability and skills (such as tying shoelaces, swimming), starting or performing a task never/sometimes = 0; often = 1

*Significant at the P < 0.05 level

Locomotor problems (parent-reported) HC healthcare setting (1 primary, 2 secondary, 3 tertiary). Data are presented as number (n) and percentage (%) aPearson’s chi-square bCoding of dummy variables: Manual dexterity: normal/increased = 0; reduced = 1 cCoding of dummy variables: Locomotor regarding stability and skills (such as tying shoelaces, swimming), starting or performing a task never/sometimes = 0; often = 1 *Significant at the P < 0.05 level

Discussion

To our knowledge, this cross-sectional study is the first to describe clinical characteristics of (concomitant) CBBD in different healthcare settings, in a large sample of 1748 affected children, visiting primary PPT-practices. In this pragmatic study, all referred children, irrespective of age, complexity of complaints, or comorbidities were included, yielding a heterogeneous cohort reflecting routinely PPT-practice. Although we have hypothesized that the prevalence’s of CBBD, comorbidities, and locomotor problems would increase going from lower-to-higher-level healthcare settings, the results of our study could only be confirmed for the physicians’ diagnoses constipation and abdominal pain and the parent-reported symptoms hard stools, abdominal pain, bloating, problems in core stability, and the existence of other health problems. In contrast, DUI, ignoring the urge to urinate and enuresis decreased going from lower-to-higher-level healthcare settings. Poor agreement exists between referred physicians’ diagnoses and questionnaire-based parent-reported symptoms. Locomotor problems prevailed in all healthcare settings. Children referred from tertiary healthcare settings experienced more problems in motor skills and core stability than those from primary and secondary settings. Some striking gender differences appeared when comparing our results with earlier studies. Significantly, more girls were suffering from constipation, abdominal pain, and urinary tract infection (physician’ diagnosis), whereas boys experienced more DUI, hard stools or painful bowel movements (parent-reported symptoms) and fecal incontinence and enuresis (physician’s diagnosis and parent-reported symptoms). Overall, estimates of presented prevalence figures differ greatly and depend not only on the clinical setting, but also on the heterogeneity of the criteria used for defining or diagnosing bladder or bowel dysfunctions. Standardized use of the accepted International Children’s Continence Society recommendations and/or the Rome III criteria for functional gastrointestinal disorders would facilitate study comparability. Concomitant CBBD was equally distributed over all three healthcare settings and diagnosed by physicians in 18.4% of the children compared to 72.4% when considering parent-reported symptoms. In fact, all parent-reported symptoms occurred more frequently than indicated by the physicians’ diagnoses, especially when considering combined bladder and bowel symptoms. This discrepancy between physicians’ diagnoses and CBBDQ outcomes may due to both, physicians and parents. When physicians focus on questioning for bladder symptoms or bowel symptoms, then concomitant CBBD will be missed. Next, is the lack of parent’s knowledge of linking complaints of CBBD. Besides, filling in questionnaires raise the attention to certain symptoms. Therefore, when a physician does not explicitly ask for all CBBD symptoms, the parents or children most likely will not report them. Therefore, caregivers should be made aware of this discrepancy, to prevent the risk of inadequately diagnosing CBBD, to promote favorable therapy outcomes, and to reduce the risk of relapses. Using a CBBD questionnaire might facilitate elicitation of all relevant symptoms. Locomotor problems prevailed in all healthcare settings. Epidemiological studies have shown that about 6% of all school-age children are described by experts and parents as uncoordinated in their fine and gross motor skills [44]. In our study, parents indicated that 14.5% of all children have had problems in motor learning and 9.2% had problems in core stability. This finding could not be explained by concomitant physical problems or comorbidities, as the number of these children was low and did not differ significantly between healthcare settings. Dysfunction of the pelvic floor muscles (PFM) and cooperating abdominal muscles is an integral component of the pathophysiology of CBBD [45-47]. Only Chase et al. [48] have examined whether different trunk musculoskeletal characteristics might be related to defecation difficulties. In agreement with our results, they found rather high prevalence rates for core stability and motor skills problems in children, supporting the hypothesis, that locomotor problems exists, indicating that dysfunctions of the muscles may be associated with CBBD [23–25, 27, 49–51]. Hence, pelvic physiotherapists, as musculoskeletal specialists, might play a role in treating children with CBBD [45, 48, 52–55]. Studies have reported that children with CBBD are at increased risk of psychosocial, behavioral, or psychological disorders [13, 56]. Although emotional or behavioral problems were present in 11.1% of the children, no association between behavioral problems and CBBD could be confirmed in all three healthcare settings. The SDQ scores did not deviate far from the norm scores reported in the literature, indicating that our sample appeared to be representative of the normal Dutch population of children aged 1–16 years. Some limitations might affect the interpretation of our findings. First, diagnoses used by physicians were based on heterogeneity of criteria. Secondly, although CBBDQ has been evaluated for validity aspects, further research is required to define its psychometric properties and to justify its use in research and clinical practice. Moreover, symptoms, indicated by the CBBDQ, were not verified by means of diagnostic testing. Then, generalization of our findings may be hampered by the fact that healthcare systems and therewith referral patterns may differ per country. Next, it is unclear if this sample of children is a typical subset of the broader population, and whether the medical doctors have referred all children with functional BBD, or only the children who failed SMC. Finally, data on the locomotor problems were obtained through parental reports and were not confirmed by a questionnaire of adequate psychometric evaluation or by musculoskeletal examination. Further, well-designed studies are necessary to assess whether children with CBBD have more locomotor problems compared to their healthy peers. Despite the aforementioned limitations, we feel that our study has strong points, such as a large sample that approximates the average patient in all healthcare settings with no restrictions regarding CBBD definition and comorbidities, and our study is one of first taking in account the motor control problems in relation to CBBD.

Conclusion

The present pragmatic study is one of the first to report the clinical characteristics of children with various forms of CBBD referred to PPT from primary, secondary, and tertiary healthcare settings. The results indicate that our hypothesis could only be confirmed for the physicians’ diagnoses constipation, abdominal pain, the existence of other health problems, and the parent-reported symptoms hard stools, bloating, and problems in core stability. More girls were suffering from constipation, abdominal pain, and urinary tract infections (physicians’ diagnoses), boys from DUI and experiencing hard stools or painful bowel movements (parent-reported symptoms) and fecal incontinence and enuresis (physicians’ diagnoses and parent-reported symptoms). The major discrepancy between physicians’ diagnoses and the symptoms, reported by the parents, raises the question whether parents are aware that their child has concomitant bladder and bowel dysfunctions when visiting a physician. Using a combined CBBD questionnaire might reduce the risk of inadequate diagnosing CBBD. Finally, locomotor problems prevailed in all healthcare settings. Since both the PFM (contributing to urination, defecation, continence, intra-abdominal pressure generation, antigravity support, and lumbo-pelvic stability) and locomotor problems might be a part of CBBD, pelvic physiotherapists can be considered to be involved in the healthcare of children affected with CBBD.
What is Known: • Childhood bladder and/or bowel dysfunctions (CCBD) are common. • Particularly tertiary healthcare characteristics of CBBD are available
What is New: • Characteristics of CBBD referred to pelvic physiotherapy are comparable in primary, secondary, and tertiary healthcare settings. • Concomitant CBBD appeared to be more prevalent than earlier reported. • Discrepancies exist between referring physicians’ diagnoses and parent-reported symptoms.
  47 in total

1.  The effect of abdominal and pelvic floor muscle activation on urine flow in women.

Authors:  Ruth R Sapsford; Paul W Hodges
Journal:  Int Urogynecol J       Date:  2012-01-26       Impact factor: 2.894

2.  Trunk strength and mobility changes in children with slow transit constipation.

Authors:  Janet W Chase; Barry C Stillman; Susan M Gibb; Melanie C C Clarke; Val J Robertson; Anthony G Catto-Smith; John M Hutson; Bridget R Southwell
Journal:  J Gastroenterol Hepatol       Date:  2009-12       Impact factor: 4.029

Review 3.  The standardization of terminology of lower urinary tract function in children and adolescents: update report from the Standardization Committee of the International Children's Continence Society.

Authors:  Paul F Austin; Stuart B Bauer; Wendy Bower; Janet Chase; Israel Franco; Piet Hoebeke; Søren Rittig; Johan Vande Walle; Alexander von Gontard; Anne Wright; Stephen S Yang; Tryggve Nevéus
Journal:  J Urol       Date:  2014-02-04       Impact factor: 7.450

4.  Dysfunctional elimination syndromes--how closely linked are constipation and encopresis with specific lower urinary tract conditions?

Authors:  Andrew J Combs; Jason P Van Batavia; Jennifer Chan; Kenneth I Glassberg
Journal:  J Urol       Date:  2013-03-29       Impact factor: 7.450

5.  Contraction of the pelvic floor muscles during abdominal maneuvers.

Authors:  R R Sapsford; P W Hodges
Journal:  Arch Phys Med Rehabil       Date:  2001-08       Impact factor: 3.966

Review 6.  The pathophysiology of monosymptomatic nocturnal enuresis with special emphasis on the circadian rhythm of renal physiology.

Authors:  L Dossche; J Vande Walle; C Van Herzeele
Journal:  Eur J Pediatr       Date:  2016-05-02       Impact factor: 3.183

7.  Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN.

Authors:  M M Tabbers; C DiLorenzo; M Y Berger; C Faure; M W Langendam; S Nurko; A Staiano; Y Vandenplas; M A Benninga
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-02       Impact factor: 2.839

8.  Pelvic-floor therapy in girls with recurrent urinary tract infections and dysfunctional voiding.

Authors:  H De Paepe; P Hoebeke; C Renson; E Van Laecke; A Raes; E Van Hoecke; J Van Daele; J Vande Walle
Journal:  Br J Urol       Date:  1998-05

9.  Psychological problems in children with daytime wetting.

Authors:  Carol Joinson; Jon Heron; Alexander von Gontard
Journal:  Pediatrics       Date:  2006-11       Impact factor: 7.124

10.  The effect of pelvic physiotherapy on reduction of functional constipation in children: design of a multicentre randomised controlled trial.

Authors:  Marieke L van Engelenburg-van Lonkhuyzen; Esther M J Bols; Marc A Benninga; Wim A Verwijs; Netty M W L Bluijssen; Rob A de Bie
Journal:  BMC Pediatr       Date:  2013-08-02       Impact factor: 2.125

View more
  2 in total

1.  The Turkish version of the childhood bladder and bowel dysfunction questionnaire (CBBDQ): Cross-cultural adaptation, reliability and construct validity.

Authors:  Gamze Aydın; Marieke L van Engelenburg-van Lonkhuyzen; Seda Baktır; Ebru Kaya Mutlu; Caner Mutlu; Rob A de Bie
Journal:  Turk J Gastroenterol       Date:  2020-06       Impact factor: 1.852

2.  Physiotherapy plus conventional treatment versus conventional treatment only in the treatment of functional constipation in children: design of a randomized controlled trial and cost-effectiveness study in primary care.

Authors:  Jojanneke J G T van Summeren; Gea A Holtman; Yvonne Lisman-van Leeuwen; Lisa E A M Louer; Alice H C van Ulsen-Rust; Karin M Vermeulen; Boudewijn J Kollen; Janny H Dekker; Marjolein Y Berger
Journal:  BMC Pediatr       Date:  2018-07-31       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.